Volume 32, Number 6—June 2026
Research
Association of Frailty and Frailty Trajectory with Risk for Respiratory Infectious Diseases
Table 3
Hazard ratios of incident RIDs in final assessment of association of frailty and frailty trajectory with risk for RIDs*
| Category | Events/no. participants | Model 1 |
Model 2 |
|||
|---|---|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |||
| Grouped by physical frailty | ||||||
| Nonfrail | 462/8,089 | Referent | Referent | |||
| Prefrail | 655/8,350 | 1.28 (1.14–1.45) | <0.001 | 1.17 (1.04–1.33) | 0.011 | |
| Frail | 72/409 | 3.04 (2.37–3.90) | <0.001 | 2.27 (1.75–2.95) | <0.001 | |
| Per 1-point increase |
1.36 (1.27–1.46) |
<0.001 |
1.25 (1.17–1.35) |
<0.001 |
||
| Grouped by frailty index | ||||||
| Nonfrail | 573/10,424 | Referent | Referent | |||
| Prefrail | 495/5,794 | 1.44 (1.27–1.62) | <0.001 | 1.28 (1.13–1.45) | <0.001 | |
| Frail | 121/630 | 3.31 (2.72–4.03) | <0.001 | 2.59 (2.10–3.19) | <0.001 | |
| Per 0.1-point increase |
1.66 (1.53–1.80) |
<0.001 |
1.48 (1.36–1.62) |
<0.001 |
||
| RID subgroups | ||||||
| Influenza | ||||||
| Grouped by physical frailty | ||||||
| Nonfrail | 9/8,089 | Referent | Referent | |||
| Prefrail | 20/8,350 | 2.04 (0.92–4.50) | 0.078 | 1.81 (0.81–4.05) | 0.146 | |
| Frail | 2/409 | 4.04 (0.87–18.81) | 0.075 | 2.36 (0.45–12.47) | 0.312 | |
| Per 1-point increase |
1.38 (0.96–1.98) |
0.079 |
1.20 (0.79–1.80) |
0.382 |
||
| Grouped by frailty index | ||||||
| Nonfrail | 18/10,424 | Referent | Referent | |||
| Prefrail | 9/5,794 | 0.85 (0.38–1.91) | 0.696 | 0.73 (0.32–1.65) | 0.443 | |
| Frail | 4/630 | 3.35 (1.12–9.98) | <0.05 | 2.09 (0.63–6.95) | 0.228 | |
| Per 0.1-point increase | 1.82 (1.15–2.90) | <0.05 | 1.53 (0.94–2.50) | 0.087 | ||
| OALRTI | ||||||
| Grouped by physical frailty | ||||||
| Nonfrail | 242/8,089 | Referent | Referent | |||
| Prefrail | 301/8,350 | 1.12 (0.94–1.33) | 0.194 | 1.03 (0.86–1.22) | 0.760 | |
| Frail | 28/409 | 2.13 (1.44–3.16) | <0.001 | 1.64 (1.09–2.48) | <0.05 | |
| Per 1-point increase | 1.22 (1.10–1.36) | <0.001 | 1.14 (1.02–1.27) | 0.024 | ||
| Grouped by frailty index | ||||||
| Nonfrail | 278/10,424 | Referent | Referent | |||
| Prefrail | 233/5,794 | 1.40 (1.18–1.67) | <0.001 | 1.28 (1.07–1.53) | 0.007 | |
| Frail | 60/630 | 3.29 (2.49–4.36) | <0.001 | 2.77 (2.06–3.73) | <0.001 | |
| Per 0.1-point increase | 1.63 (1.45–1.83) | <0.001 | 1.51 (1.32–1.71) | <0.001 | ||
| Pneumonia | ||||||
| Grouped by physical frailty | ||||||
| Nonfrail | 247/8,089 | Referent | Referent | |||
| Prefrail | 408/8,350 | 1.47 (1.26–1.73) | <0.001 | 1.34 (1.14–1.58) | <0.001 | |
| Frail | 53/409 | 4.12 (3.06–5.55) | <0.001 | 2.96 (2.16–4.05) | <0.001 | |
| Per 1-point increase | 1.53 (1.40–1.67) | <0.001 | 1.39 (1.27–1.52) | <0.001 | ||
| Grouped by frailty index | ||||||
| Nonfrail | 320/10,424 | Referent | Referent | |||
| Prefrail | 312/5,794 | 1.58 (1.35–1.84) | <0.001 | 1.38 (1.17–1.62) | <0.001 | |
| Frail | 76/630 | 3.53 (2.75–4.55) | <0.001 | 2.67 (2.04–3.50) | <0.001 | |
| Per 0.1-point increase | 1.73 (1.56–1.92) | <0.001 | 1.52 (1.35–1.70) | <0.001 | ||
*Data from UK Biobank (https://www.ukbiobank.ac.uk) collected during 2012–2013. Model 1 is adjusted for age and sex; model 2 is adjusted for all covariates. HRs and 95% CIs were estimated using Cox proportional hazards models. A 2-sided p<0.05 was considered statistically significant. FI, frailty index; HR, hazard ratio; OALRTI, other acute lower respiratory tract infection; PF, physical frailty; RID, respiratory infectious disease.
1These first authors contributed equally to this article.
Page created: April 22, 2026
Page updated: June 01, 2026
Page reviewed: June 01, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.